MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceutical Drug Discovery & Development_Artificial Intelligence (AI) & Machine Learning (ML)
Isomorphic Labs
Organization & Developments: Isomorphic Labs
Parents
Isomorphic Labs
Children
*Building on the AlphaFold breakthrough in active partnership with Google DeepMind, united together as members of the Alphabet family.
*Isomorphic Laboratories specializes in the drug discovery process with an AI-first approach.
*The core product is IsoDDE, known as the Isomorphic Drug Design Engine, which predicts how potential drug compounds will interact with proteins in the body.
2021: Isomorphic Labs is Alphabet’s play in AI drug discovery – TechCrunch
2023: A glimpse of the next generation of AlphaFold
2024: Isomorphic inks deals with Eli Lilly and Novartis for drug discovery
2025: $600 million round, led by Thrive Capital with participation from GV. The company has existing partnerships with pharma giants Novartis and Eli Lilly, which help (among other things) deliver a vital piece in Isomorphic’s pursuit—data.
2025: Demis Hassabis on Isomorphic’s $600 million raise, AI, and healthcare’s future
2025: Isomorphic Labs secures $600M in funding for AI drug design
2025: Thrive Capital led the round, with participation from GV (Google Ventures) and existing investor Alphabet.
2026: AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
2026: Google-backed Isomorphic Labs delays clinical trial timeline
2026: Our approach to bioresilience ... Google DeepMind and Isomorphic Labs
Jumps
Finance & Acquisitions: Isomorphic Labs
Key People: Isomorphic Labs